Home › Funds › GLENMEDE TRUST CO NA › LLY
GLENMEDE TRUST CO NA position in LLY
ELI LILLY & CO · Health Care
GLENMEDE TRUST CO NA reported holding 314,370 shares of LLY (ELI LILLY & CO) in its Q3 2026 13F filing — a position valued at US$239.9M, representing 1.17% of its reported portfolio and ranking #15 among its reported holdings. GLENMEDE TRUST CO NA has disclosed LLY holdings in 9 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How GLENMEDE TRUST CO NA's LLY position evolved
GLENMEDE TRUST CO NA first disclosed a stake in LLY in Q3 2023 at 409,651 shares (US$220.0M). The position peaked in Q2 2026 at 300,851 shares, worth US$360.8M. Across 9 filings, GLENMEDE TRUST CO NA increased the stake 2 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 314,370 shares valued at US$239.9M — an increase of 13,519 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 409.65K | $220.04M | New |
| Q4 2023 | 394.81K | $230.14M | Reduce |
| Q3 2024 | 356.30K | $315.66M | Reduce |
| Q4 2024 | 328.85K | $253.88M | Reduce |
| Q1 2025 | 311.96K | $257.65M | Reduce |
| Q4 2025 | 317.62K | $341.34M | Add |
| Q1 2026 | 306.83K | $282.21M | Reduce |
| Q2 2026 | 300.85K | $360.85M | Reduce |
| Q3 2026 | 314.37K | $239.86M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LLY and 13F data
LLY (ELI LILLY & CO) is a Health Care company. 34 other funds we track also report a position in LLY — the largest reported positions include LILLY ENDOWMENT INC (US$104.21B), Vanguard Group (US$88.09B), VANGUARD CAPITAL MANAGEMENT LLC (US$62.39B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LLY
- LILLY ENDOWMENT INC 90.07M sh · $104.21B · Q3 2026
- Vanguard Group 81.97M sh · $88.09B · Q4 2025
- VANGUARD CAPITAL MANAGEMENT LLC 53.92M sh · $62.39B · Q3 2026
- PNC Financial Services 51.30M sh · $59.35B · Q3 2026
- STATE STREET CORP 36.85M sh · $42.64B · Q3 2026
- Fidelity Management & Research (FMR) 29.96M sh · $34.67B · Q3 2026
- Capital Research Global Investors 20.87M sh · $25.04B · Q2 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 21.00M sh · $24.30B · Q3 2026
- GEODE CAPITAL MANAGEMENT, LLC 20.31M sh · $24.28B · Q2 2026
- Geode Capital Management 20.56M sh · $23.72B · Q3 2026
- Capital Research Global Investors 17.00M sh · $19.67B · Q3 2026
- Capital World Investors 15.90M sh · $19.08B · Q2 2026
More on GLENMEDE TRUST CO NA
FAQ
How long has GLENMEDE TRUST CO NA held LLY?
GLENMEDE TRUST CO NA has disclosed LLY holdings in 9 of the last 13 reported quarters, going back to Q3 2023.
What is GLENMEDE TRUST CO NA's current position in LLY?
As of Q3 2026, GLENMEDE TRUST CO NA holds 314.37K shares of LLY (ELI LILLY & CO), valued at $239.86M, representing 1.17% of its reported portfolio and ranking #15.
Has GLENMEDE TRUST CO NA been buying or selling LLY?
In the latest 13F filing (Q3 2026), GLENMEDE TRUST CO NA increased its position in LLY. The position peaked in Q2 2026 at 300.85K shares.
Which other funds hold LLY?
Other major institutional holders of LLY include LILLY ENDOWMENT INC, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 34 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.